VCYT Veracyte, Inc.
Healthcare$44.21-1.82%ClosedMarket Cap: $3.53B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$45.25
Target (Median)
$46.00
Target Range
$37.00 - $52.00
Upside from current price: 2.4%
Rating Distribution
1 Strong Buy9 Buy1 Hold1 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | UBS | maintain | Buy | Buy |
| 2026-05-06 | Canaccord Genuity | maintain | Hold | Hold |
| 2026-04-01 | Needham | maintain | Buy | Buy |
| 2026-03-30 | Guggenheim | maintain | Buy | Buy |
| 2026-03-06 | Morgan Stanley | maintain | Underweight | Underweight |
| 2026-02-26 | Needham | maintain | Buy | Buy |
| 2026-01-05 | Guggenheim | maintain | Buy | Buy |
| 2025-12-02 | Morgan Stanley | maintain | Underweight | Underweight |
| 2025-11-05 | Guggenheim | maintain | Buy | Buy |
| 2025-11-05 | Needham | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $1.91 | $654.9M | 6 |
| Sun Dec 31 | $2.01 | $719.4M | 4 |
| Mon Dec 31 | $2.17 | $804.6M | 2 |
| Tue Dec 31 | $2.34 | $879.0M | 2 |